Policy, Legal & Regulatory

sunosi
Pharmaceuticals & Therapuetics Policy, Legal & Regulatory Product & Vendor Updates

Axsome Drops Sunosi Patent Litigation Against Sandoz Generic

Axsome Therapeutics, Inc. announced that it has reached an agreement with Sandoz Inc. (Sandoz) to dismiss the patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from submission by Sandoz of an Abbreviated New Drug […]

vanda loses patent
Policy, Legal & Regulatory

Vanda Loses Patents on Hetlioz Sleep Drug

  Vanda Pharmaceuticals Inc. today responded to the ruling in its Hetlioz® Abbreviated New Drug Application appeal. Today a three-judge panel of the United States Court of Appeals for the Federal Circuit issued a written opinion that affirmed a December 13, 2022, decision of the United States District Court for the District of Delaware, […]